HIGH-DOSE MELPHALAN AND AUTOLOGOUS BONE-MARROW TRANSPLANT AS TREATMENT FOR REFRACTORY HODGKINS-DISEASE

被引:0
|
作者
SELBY, PJ [1 ]
MBIDDE, EK [1 ]
MAITLAND, J [1 ]
MCELWAIN, TJ [1 ]
机构
[1] ROYAL MARSDEN HOSP,INST CANC RES,SUTTON,SURREY,ENGLAND
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:612 / 612
页数:1
相关论文
共 50 条
  • [1] TREATMENT OF ADVANCED HODGKINS-DISEASE WITH HIGH-DOSE MELPHALAN AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION
    RUSSELL, JA
    SELBY, PJ
    RUETHER, BA
    MBIDDE, EK
    ASHLEY, S
    ZULIAN, G
    BERRY, J
    HOUWEN, B
    JONES, AR
    POON, MC
    BLAHEY, WB
    BRADA, M
    NANDI, A
    GEGGIE, PHS
    GORE, ME
    MCELWAIN, TJ
    BONE MARROW TRANSPLANTATION, 1989, 4 (04) : 425 - 429
  • [2] HIGH-DOSE MELPHALAN, BCNU AND ETOPOSIDE WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR HODGKINS-DISEASE
    ZULIAN, GB
    SELBY, P
    MILAN, S
    NANDI, A
    GORE, M
    FORGESON, G
    PERREN, TJ
    MCELWAIN, TJ
    BRITISH JOURNAL OF CANCER, 1989, 59 (04) : 631 - 635
  • [3] HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN REFRACTORY HODGKINS-DISEASE
    PHILIP, T
    DUMONT, J
    TEILLET, F
    MARANINCHI, D
    GORIN, NC
    KUENTZ, M
    HAROUSSEAU, JL
    MARTY, M
    PINKERTON, R
    HERVE, P
    BRITISH JOURNAL OF CANCER, 1986, 53 (06) : 737 - 742
  • [4] TREATMENT OF RELAPSED AND REFRACTORY HODGKINS-DISEASE WITH HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION
    BRICE, P
    GISSELBRECHT, C
    FERME, C
    LEPAGE, E
    BARUCHEL, A
    MAROLLEAU, JP
    GEROTA, O
    BOIRON, M
    NOUVELLE REVUE FRANCAISE D HEMATOLOGIE, 1991, 33 (03): : 267 - 272
  • [5] HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR RELAPSED AND REFRACTORY HODGKINS-DISEASE
    HARDING, M
    SELBY, P
    GORE, M
    PERREN, T
    TRELEAVAN, J
    MANSI, J
    ZULIAN, G
    MILAN, S
    MELDRUM, M
    VINER, C
    MCELWAIN, TJ
    EUROPEAN JOURNAL OF CANCER, 1992, 28A (8-9) : 1396 - 1400
  • [6] SUCCESSFUL TREATMENT OF REFRACTORY HODGKINS-DISEASE BY HIGH-DOSE COMBINATION CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION
    GRIBBEN, JG
    LINCH, DC
    SINGER, CRJ
    MCMILLAN, AK
    JARRETT, M
    GOLDSTONE, AH
    BLOOD, 1989, 73 (01) : 340 - 344
  • [7] HIGH-DOSE ETOPOSIDE AND MELPHALAN, AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR PATIENTS WITH ADVANCED HODGKINS-DISEASE - IMPORTANCE OF DISEASE STATUS AT TRANSPLANT
    CRUMP, M
    SMITH, AM
    BRANDWEIN, J
    COUTURE, F
    SHERRET, H
    SUTTON, DMC
    SCOTT, JG
    MCCRAE, J
    MURRAY, C
    PANTALONY, D
    SUTCLIFFE, SB
    KEATING, A
    JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (04) : 704 - 711
  • [8] TREATMENT OF RESISTANT OR RELAPSING HODGKINS-DISEASE WITH HIGH-DOSE CHEMOTHERAPY FOLLOWED BY AUTOLOGOUS BONE-MARROW TRANSPLANT
    DOMINGOALBOS, A
    GARCIA, J
    PUIG, J
    BRUNET, S
    AYATS, R
    PARDO, N
    SOLER, J
    MUNIZ, E
    BADELL, I
    MEDICINA CLINICA, 1990, 94 (09): : 321 - 324
  • [9] THE ROLE OF HIGH-DOSE THERAPY AND AUTOLOGOUS BONE-MARROW REINFUSION IN THE TREATMENT OF HODGKINS-DISEASE
    WILLIAMS, SF
    BITRAN, JD
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1989, 3 (02) : 319 - 330
  • [10] FACTORS INFLUENCING SURVIVAL IN RELAPSED OR REFRACTORY HODGKINS-DISEASE TREATED BY HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANT
    AHMED, T
    COOK, P
    BEER, M
    RAZIS, E
    FELDMAN, E
    LAKE, D
    MITTELMAN, A
    ALI, M
    PRETI, R
    BLOOD, 1993, 82 (10) : A147 - A147